Literature DB >> 12958394

Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample.

S Shiffman1, J R Hughes, J L Pillitteri, S L Burton.   

Abstract

BACKGROUND: In 1996, the US Food and Drug Administration (FDA) approved switching nicotine gum and patch from prescription to over-the-counter (OTC) status. Some expressed concerns that broader availability and lack of physician control might increase persistent use of nicotine replacement therapy (NRT)-that is, use beyond the period specified by the FDA approved label.
OBJECTIVE: To estimate the incidence of persistent use of OTC nicotine gum and patch for periods of > 3 months, > or = 6 months, > or = 12 months, and > or 24 months.
DESIGN: Analysis of NRT purchase patterns in data from a population based panel of US households that electronically scanned all household purchases between January 1997 and March 2000.
SUBJECTS: In a national panel of 40,000 US households, 2690 recorded NRT purchases.
RESULTS: Among 805 households that purchased nicotine gum, 2.3% of new purchase incidents led to continuous monthly purchase of gum for > or = 6 months. For nicotine patches (2050 households) the percentage was 0.9%. For both gum and patch, the incidence of persistent purchase dropped below 0.4% by 24 months. Allowing one month gaps within a "continuous" purchase run resulted in increased estimates (for gum: 6.7% for > or = 6 months and 1.0% for > or = 24 months; for patch: 1.7% for > or = 6 months and 0.05% for > or = 24 months).
CONCLUSION: Persistent use of nicotine gum and patch is very rare and has not increased with the transition to OTC use, despite removal of physician oversight.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958394      PMCID: PMC1747733          DOI: 10.1136/tc.12.3.310

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  29 in total

1.  Why does smoking so often produce dependence? A somewhat different view.

Authors:  J R Hughes
Journal:  Tob Control       Date:  2001-03       Impact factor: 7.552

2.  A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches.

Authors:  R V Fant; J E Henningfield; S Shiffman; K R Strahs; D P Reitberg
Journal:  Pharmacol Biochem Behav       Date:  2000-11       Impact factor: 3.533

Review 3.  A meta-analysis of the efficacy of over-the-counter nicotine replacement.

Authors:  J R Hughes; S Shiffman; P Callas; J Zhang
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

4.  A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler.

Authors:  R West; P Hajek; J Foulds; F Nilsson; S May; A Meadows
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

Review 5.  Recent advances in the pharmacotherapy of smoking.

Authors:  J R Hughes; M G Goldstein; R D Hurt; S Shiffman
Journal:  JAMA       Date:  1999-01-06       Impact factor: 56.272

6.  Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public.

Authors:  J F Etter; T V Perneger
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

7.  Dependence on nicotine chewing gum.

Authors:  R J West; M A Russell
Journal:  JAMA       Date:  1986-12-19       Impact factor: 56.272

8.  Real-world efficacy of prescription and over-the-counter nicotine replacement therapy.

Authors:  Saul Shiffman; Clyde N Rolf; Stephen J Hellebusch; Jane Gorsline; Charles W Gorodetzky; Yu-Kun Chiang; Debra S Schleusener; Michael E Di Marino
Journal:  Addiction       Date:  2002-05       Impact factor: 6.526

Review 9.  Changing the status of drugs from prescription to over-the-counter availability.

Authors:  E P Brass
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

10.  Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation.

Authors:  John P Pierce; Elizabeth A Gilpin
Journal:  JAMA       Date:  2002-09-11       Impact factor: 56.272

View more
  21 in total

1.  Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts.

Authors:  Douglas E Levy; Anne N Thorndike; Lois Biener; Nancy A Rigotti
Journal:  Tob Control       Date:  2007-12       Impact factor: 7.552

2.  Nicotine replacement therapy for smoking cessation in the "real world".

Authors:  Saul Shiffman
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

Review 3.  Toward a comprehensive long term nicotine policy.

Authors:  N Gray; J E Henningfield; N L Benowitz; G N Connolly; C Dresler; K Fagerstrom; M J Jarvis; P Boyle
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

4.  A prospective study of off-label use of, abuse of, and dependence on nicotine inhaler.

Authors:  J R Hughes; E H Adams; M A Franzon; M K Maguire; J Guary
Journal:  Tob Control       Date:  2005-02       Impact factor: 7.552

5.  Dependence on tobacco and nicotine products: a case for product-specific assessment.

Authors:  Karl Fagerström; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2012-03-29       Impact factor: 4.244

6.  U.S. adults' addiction and harm beliefs about nicotine and low nicotine cigarettes.

Authors:  Erin Keely O'Brien; Anh B Nguyen; Alexander Persoskie; Allison C Hoffman
Journal:  Prev Med       Date:  2016-12-27       Impact factor: 4.018

Review 7.  Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?

Authors:  Nancy Amodei; R J Lamb
Journal:  Psychol Addict Behav       Date:  2008-12

8.  Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.

Authors:  David Hammond; Jessica L Reid; Pete Driezen; K Michael Cummings; Ron Borland; Geoffrey T Fong; Ann McNeill
Journal:  Addiction       Date:  2008-10       Impact factor: 6.526

Review 9.  Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.

Authors:  Jack E Henningfield; Saul Shiffman; Stuart G Ferguson; Ellen R Gritz
Journal:  Pharmacol Ther       Date:  2009-04-08       Impact factor: 12.310

10.  Examining e-cigarette purchases and cessation in a consumer panel of smokers.

Authors:  Zachary Cahn; Regine Haardörfer; Michael Lewis; Yanwen Wang; Carla J Berg
Journal:  J Smok Cessat       Date:  2018-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.